» Articles » PMID: 17935133

Exogenous Expression of Esophagin/SPRR3 Attenuates the Tumorigenicity of Esophageal Squamous Cell Carcinoma Cells Via Promoting Apoptosis

Overview
Journal Int J Cancer
Specialty Oncology
Date 2007 Oct 16
PMID 17935133
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Esophagin/SPRR3 is one of the cornified-envelope structural precursor proteins, which is expressed during epithelia cell differentiation. In 1996, another research group discovered, and our own laboratory subsequently confirmed, frequent and dramatic decreased Esophagin/SPRR3 expression in esophageal squamous cell carcinoma (ESCC). However, the role of Esophagin/SPRR3 in tumorigenesis of esophageal epithelium remains undetermined. In this study, we demonstrate that expression of Esophagin/SPRR3 is frequently downregulated in ESCC. In contrast, no correlations between downregulation of Esophagin/SPRR3 expression and clinicopathologic characteristics were observed. Diminished Esophagin/SPRR3 expression was present in dysplastic epithelia, suggesting that Esophagin/SPRR3 alteration could represent an early event in squamous carcinogenesis of the esophagus. Exogenous expression of Esophagin/SPRR3 significantly suppressed the ability of ESCC cells to form colonies in plastic and soft agar, as well as tumor formation in vivo. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end label assay and immunofluorescence analysis of the active form of Caspase 3 indicated that dysregulated apoptosis might contribute to reduced tumorigenicity. In particular, upregulation of CDK11p46 protein was observed in ESCC cells expressing Esophagin/SPRR3, but not in control cells, indicating that Esophagin/SPRR3-induced apoptosis may be due, at least in part, to increased expression of CDK11p46 protein. These findings suggest that Esophagin/SPRR3 may play a role in the maintenance of normal esophageal epithelial homeostasis, and that aberrant expression of Esophagin/SPRR3 may contribute to the tumorigenesis of ESCC.

Citing Articles

Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis.

Guo Q, Lu T, Xu H, Luo Q, Liu Z, Jiang S Cancer Rep (Hoboken). 2023; 6(5):e1808.

PMID: 37092360 PMC: 10172170. DOI: 10.1002/cnr2.1808.


SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-B Signaling Pathway.

Xie Y, Li H, Zhong B, Zhu X, Ye R, Xie B Biomed Res Int. 2023; 2023:7518744.

PMID: 36685674 PMC: 9859694. DOI: 10.1155/2023/7518744.


SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma via the PI3K/Akt signaling pathway.

Wu M, Guo Q, Liu X, Wu L Exp Ther Med. 2022; 23(5):317.

PMID: 35350667 PMC: 8943802. DOI: 10.3892/etm.2022.11246.


DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer.

Wang Z, Li Y, Mao R, Zhang Y, Wen J, Liu Q Cell Death Dis. 2022; 13(2):151.

PMID: 35165262 PMC: 8844036. DOI: 10.1038/s41419-022-04599-x.


Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.

Pandey R, Zhou M, Chen Y, Darmoul D, Kisiel C, Nfonsam V Genes (Basel). 2021; 12(5).

PMID: 34065672 PMC: 8157155. DOI: 10.3390/genes12050749.